What is the treatment for a Group G streptococcal (GGS) positive throat culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group G Streptococcal Pharyngitis

Group G streptococcus (GGS) pharyngitis should be treated similarly to Group A streptococcal pharyngitis with penicillin or amoxicillin for 10 days, as the available guidelines and evidence focus on Group A streptococcus but the same antibiotic principles apply to other beta-hemolytic streptococci including Group G.

Important Clinical Context

The provided evidence exclusively addresses Group A streptococcal (GAS) pharyngitis, not Group G streptococcus. However, Group G streptococcus is also a beta-hemolytic streptococcus that causes pharyngitis and responds to the same antibiotics as Group A streptococcus. In clinical practice, Group G streptococcal pharyngitis is managed with identical antibiotic regimens.

First-Line Treatment Approach

  • Penicillin remains the treatment of choice due to its proven efficacy, safety, narrow spectrum, and low cost 1

  • Oral penicillin V dosing:

    • Children: 250 mg twice or three times daily for 10 days 2
    • Adolescents and adults: 250 mg four times daily or 500 mg twice daily for 10 days 2
  • Amoxicillin is equally effective and often preferred in young children due to better taste acceptance, dosed at 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg) for 10 days 2

  • Intramuscular benzathine penicillin G is preferred for patients unlikely to complete a full 10-day oral course 1

Alternative Antibiotics for Penicillin-Allergic Patients

  • For non-immediate hypersensitivity reactions: First-generation cephalosporins (e.g., cephalexin 20 mg/kg twice daily, maximum 500 mg/dose) for 10 days 2, 3

  • For immediate-type hypersensitivity: Clindamycin for 10 days (7 mg/kg three times daily, maximum 300 mg/dose) 4, 2

  • Macrolides (erythromycin, azithromycin) are suitable alternatives, though macrolide resistance should be considered, particularly with multiple prior macrolide courses 1, 4, 2

Critical Treatment Duration

  • A full 10-day course is mandatory for all oral antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent complications 2, 3

  • Azithromycin requires only 5 days due to its prolonged tissue half-life 3

  • Shorter courses increase the risk of treatment failure and complications 2, 3

Treatment Goals (in Priority Order)

  1. Prevention of suppurative complications (peritonsillar abscess, cervical lymphadenitis, mastoiditis) - this is the primary concern with Group G streptococcus, as acute rheumatic fever is primarily associated with Group A streptococcus 2

  2. Abatement of clinical symptoms and reduction in transmission to close contacts 1

  3. Minimization of adverse effects from inappropriate antimicrobial therapy 1

Common Pitfalls to Avoid

  • Do not use shorter antibiotic courses (<10 days for oral therapy) despite some literature suggesting efficacy 2

  • Avoid routine post-treatment testing in asymptomatic patients who completed therapy, as this leads to unnecessary retreatment of carriers 4, 2

  • Do not prescribe tetracyclines, sulfonamides, trimethoprim-sulfamethoxazole, or older fluoroquinolones, which are not effective against streptococci 4

  • Avoid cephalosporins in patients with immediate-type hypersensitivity to penicillin due to 10% cross-reactivity risk 2, 3

Management of Treatment Failure or Recurrence

  • Perform throat culture if symptoms persist or recur after completing therapy 4

  • Consider alternative antibiotics such as clindamycin, amoxicillin-clavulanate, or first-generation cephalosporins for retreatment 4, 2

  • Clindamycin is particularly effective for eradicating streptococci in carrier states and recurrent episodes 4, 5

  • Evaluate for carrier state with intercurrent viral infection, non-compliance, or new infection from contacts 4, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Group A Streptococcus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternatives to IM Antibiotic Injection for Complicated Strep Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Persistent Sore Throat After Completed Azithromycin Course for Strep Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.